Winslow Asset Management Inc Bristol Myers Squibb CO Transaction History

Winslow Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $143 - $84,524	-1,100 Reduced 27.36%	2,921 $208,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $29,817 - $35,754	-485 Reduced 10.76%	4,021 $294,000
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $5,685 - $6,300	-99 Reduced 2.15%	4,506 $272,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $5,591 - $6,537	-102 Reduced 2.17%	4,605 $271,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $16,240 - $23,600	-350 Reduced 6.92%	4,707 $262,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $9,891 - $12,902	201 Added 4.14%	5,057 $325,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $17,108 - $20,284	-400 Reduced 7.61%	4,856 $246,000
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $6,693 - $7,401	-150 Reduced 2.77%	5,256 $238,000
Q3 2018 Oct 18, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 3.57%	5,406 $336,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $309,619 - $357,326	5,606	5,606 $357,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Winslow Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Winslow Asset Management Inc with notifications on news.